News tagged with lancet

T-cell targeted therapy tested in type 1 diabetes study

Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network (ITN), ...

Aug 27, 2013
popularity 4.7 / 5 (3) | comments 0